Bidirectional regulation of P body formation mediated by eIF4F complex formation in sensory neurons.
Processing (P) bodies are RNA granules that comprise key cellular sites for the metabolism of mRNAs. In certain cells, including neurons, these RNA granules may also play an important role in storage of mRNAs in a translationally dormant state. Utilizing nerve growth factor (NGF) and interleukin 6 (IL6), which stimulate cap-dependent translation in sensory neurons, and adenosine monophosphate activated protein kinase (AMPK) activators, which inhibit cap-dependent translation, we have tested the hypothesis that cap-dependent translation is linked to P body formation in mammalian sensory neurons. Treatment with NGF and IL6 decreases, whereas metformin increases biochemical association of the P body marker and translational repressor/decapping activator Rck/p54/dhh1 with the 5'-mRNA-cap suggesting an ordered assembly of P bodies. Likewise, diverse AMPK activators enhance P body formation while NGF and IL6 decrease P bodies in sensory neurons. This bidirectional P body plasticity readily occurs in the axonal compartment of these neurons. These studies indicate that P body formation is intricately linked to cap-dependent translation in mammalian sensory neurons suggesting an important role for these organelles in the regulation of mRNA metabolism in the adult PNS.
Department of Pharmacology, University of Arizona, Tucson, AZ, United States. Electronic address: ohannes@email.arizona.edu.
Ohannes K
OK
Melemedjian
Department of Pharmacology, University of Arizona, Tucson, AZ, United States. Electronic address: gmejia@email.arizona.edu.
Galo L
GL
Mejia
Department of Pharmacology, University of Arizona, Tucson, AZ, United States. Electronic address: talyal@email.arizona.edu.
Talya S
TS
Lepow
Department of Pharmacology, University of Arizona, Tucson, AZ, United States. Electronic address: Olivia_zoph@yahoo.com.
Olivia K
OK
Zoph
Department of Pharmacology, University of Arizona, Tucson, AZ, United States. Electronic address: tjprice@email.arizona.edu.
Theodore J
TJ
Price
D055372:AMP-Activated Protein Kinases / Q000378:metabolism; D000818:Animals; D001369:Axons / Q000378:metabolism; D002478:Cells, Cultured; D022083:Cytoplasmic Structures / Q000378:metabolism*; D020536:Enzyme Activators / Q000494:pharmacology; D039562:Eukaryotic Initiation Factor-4F / Q000378:metabolism*; D015850:Interleukin-6 / Q000494:pharmacology; D008297:Male; D008813:Mice, Inbred ICR; D020932:Nerve Growth Factor / Q000494:pharmacology; D012313:RNA / Q000378:metabolism*; D012315:RNA Caps / Q000378:metabolism; D011984:Sensory Receptor Cells / Q000378:metabolism*; D012668:Trigeminal Ganglion / Q000166:cytology
D020536:Enzyme Activators; D039562:Eukaryotic Initiation Factor-4F; D015850:Interleukin-6; D012315:RNA Caps; D012313:RNA; D020932:Nerve Growth Factor; D055372:AMP-Activated Protein Kinases
AMPK; P bodies; Translation initiation; Trigeminal ganglion; eIF4F; mRNA degradation